Expression of recombinant CD59 with an N-terminal peptide epitope facilitates analysis of residues contributing to its complement-inhibitory function

Molecular Immunology

Volumn 33, Issue 14, 1997, Pages 1127-1134

  Zhou, Quansheng ^a   Zhao, Ji ^a   Hüsler, Thomas ^a   Sims, Peter J ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

CD59; complement; complement inhibitors; mutagenesis; protein structure

Indexed keywords

CD59 ANTIGEN; COMPLEMENT; COMPLEMENT INHIBITOR; EPITOPE; RECOMBINANT PROTEIN;

ARTICLE; HUMAN; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD59; COMPLEMENT INACTIVATOR PROTEINS; EPITOPES; HUMANS; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; RECOMBINANT PROTEINS;

EID: 0030267244     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(96)00074-0     Document Type: Article

References (20)

1. Chen C. and Okayama H. (1988) Calcium phosphate-mediated gene transfer: A highly efficient system for stably transforming cells with plasmid DNA. Biotechniques 6, 632-638.
2. Cheng K., Wiedmer T. and Sims P. J. (1985) Fluorescence resonance energy transfer study of the associative state of membrane bound complexes of complement proteins C5b-8. J. Immun. 135, 459-464.
3. Davies A. and Lachmann P. J. (1993) Membrane defence against complement lysis: The structure and biological properties of CD59. Immun. Res. 12, 258-275.
4. Fletcher C. M., Harrison R. A., Lachmann P. J. and Neuhaus D. (1993) Sequence-specific 1H-NMR assignments and folding topology of human CD59. Protein Sci. 2, 2015-2027.
5. Fletcher C. M., Harrison R. A., Lachmann P. J. and Neuhaus D. (1994) Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. Structure 2, 185-199.
6. Fraker P. J. and Speck Jr J. C. (1978) Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80, 849-857.
7. Kieffer B., Driscoll P. C., Campbell I. D., Willis A. C., Merwe P. A. van der and Davis S. J. (1994) Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins. Biochemistry 33, 4471-4482.
8. Meri S., Morgan B. P., Davies A., Daniels R. H., Olavesen M. G., Waldmann H. and Lachmann P. J. (1990) Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71, 1-9.
9. Munro S. and Pelham H. (1986) An Hsp-70-like protein in the ER: identity with the 78 Kd glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell 46, 291-300.
10. Ninomiya H., Stewart B. H., Rollins S. A., Zhao J., Bothwell A. L. and Sims P. J. (1992) Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity. J. Biol. Chem. 267, 8404-8410.
11. Okada H., Nagami Y., Takahashi K., Okada N., Hideshima T., Takizawa H. and Kondo J. (1989) 20 kDa homologous restriction factor of complement resembles T cell activating protein. Biochem. Biophys. Res. Commun. 162, 1553-1559.
12. Petranka J., Norria J., Hall S., Zhao J., Tweedy N., Bothwell A., Sims P. J. and Rosse W. F. (1993) The structure and function of CD59: The importance of the disulfide structure and identification of a primary epitope. Mol. Immun. 30(Suppl), 44.
13. Potter H., Weir L. and Leder P. (1984) Enhancer-dependent expression of human K immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc. natn. Acad. Sci. U.S.A. 81, 7161-7165.
14. Rollins S. A. and Sims P. J. (1990) Complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J. Immun. 144, 3478-3483.
15. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B. and Erlich H. A. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487-491.
16. Sawada R., Ohashi K., Okano K., Hattori M., Minato N. and Naruto M. (1989) Complementary DNA sequence and deduced peptide sequence for CD59/MEM-43 antigen, the human homologue of murine lymphocyte antigen Ly-6C. Nuc. Acids Res. 17, 6728.
17. Sims P. J. (1984) Complement protein C9 labeled with fluorescein isothiocyanate can be used to monitor C9 polymerization and formation of the cytolytic membrane lesion. Biochemistry 23, 3248-3260.
18. Tabor S. and Richardson C. C. (1989) Selective inactivation of the exonuclease activity of bacteriophage T7 DNA polymerase by in vitro mutagenesis. J. Biol. Chem. 264, 6447-6458.
19. Van Nostrand W. E., Wagner S. L., Suzuki M., Choi B. H., Farrow J. S., Geddes J. W., Cotman C. W. and Cunningham D. D. (1989) Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid β-protein precursor. Nature 341, 546.
20. Zhao J., Rollins S. A., Maher S. E., Bothwell A. L. and Sims P. J. (1991) Amplified gene expression in CD59-transfected Chinese hamster ovary cells confers protection against the membrane attack complex of human complement. J. Biol. Chem. 266, 13418-13422.